Yosephine Ratih Ismayanti

Support global ambition by providing female talent on top management

a. Maintain equal career opportunities to all employees regardless of gender

b. Break “glass ceiling” stigma to help female employees reach their career aspiration

c. Reduce gender bias in people manager

Support General Manager in identifying strategic initiatives that will enable the GBU to accomplish budget
o Drive identified key strategic projects by working with different business units director/ functions
o Support General Manager on monthly tracking of key projects, timelines, and budget in collaboration with BU Heads/ directors to ensure high quality & on-time deliver

In collaboration with BUs, Performance Management Business Partner analyses performance and identifies insights in order to drive excellence in execution and higher sustainable performance

Internal Projects

a. Hybrid Way of Working

Ensuring MR productivities to customer through traditional and digital channel during new normal

b. Hospital Profiling Segmentation and Targeting

Objective: Increase sales volume in targeted-potential hospital and put the resources in the right segment

exploring opportunity in high potential hospital and ensuring the penetration major product in each BU

c. PST (Positioning Segmentation and Targetting) for Cardiothrombo Team

Lead PST process in CT team. This process is too replace 2019 PST

Responsible in Insulin Product: Apidra, Lantus and Lantus XR

· To implement product sales strategy and marketing programs to sales management team and medical professionals in assigned therapeutic areas.

Achievement:

2017:

1. Launch Lantus XR

2. Maintain Lantus as a market Leader in Basal Class (IMS Q3 2017)

57%MS in Basal insulin market with 14% GR vs LY

3.Increase market Share for Apidra in Rapid Class (IMS Q3 2017)

15% MS in Rapid Insulin Market with 45% GR vs LY

2018

1. Meet B18 Glargine Sales and grow 16% vs A17

2. Protecting Glargine in JKN market: Gain MS 58%, increase share vs LY (IQVIA 2018)

Project:

1.Strengthen the role Apidra in inpatient diabetes management through building ecosystem in hospital with holistic approach

Collaborative effort Medico-Marketing and Sales team to deliver workshop proposal to get endorsement from hospital / associations (Endo/Intensivist)

2. Launching Lantus XR

ensure the succeed of launch Lantus XR.

Result: Lantus XR got accelerate 6 months, and successful launched in September.

During 5 days launching, There were 15 HCPs prescribe Lantus XR, 1 hospital ordered 2 boxes of Lantus Xr and 17 Pharmacies ordered 24 boxes of Lantus XR

Handling Novartis products related to Cardio Vascular and Metabolic portfolio
Latest position was under BUH and supervised Product manager and Product Executive

Internal Project

Maintain Exforge as a market Leader in SPC Class in Indonesia in 2017
Successfully launched 2nd brand of Galvus, Durvik
Successfully launched new indication: Galvus add on insulin
Successfully launched Indonesia Ramadan Guideline in 2015. Collaborated with PERKENI

Responsible in Osteoporosis Product

· Successfully brought Bonviva as a market leader in Osteoporosis Products in 2015

· Successfully launched HERO (High Efficacy to Reduce Osteoporosis) Project,

· Based on IPSOS market Research 2015, Bonviva got a highest key message recall compared to others.

· Successfully launched 3 T layman campign (Talk, Test and Treat) to fight osteoporosis. This project collaborated with HILO (Osteoporosis nutrition)

Successfully to run BoneDiva (Patient support Program), this program had an objective to ensure osteoporosis patient comply and adherence in osteoporosis therapy

Experience in anesthesia and solution area

The first champion of Conim (Continous Improvement) for A3 report Category in Holictic Care department, PT Kalbe Farma (2012)

Top 10 “Idea to Customer” 2011 in PT. Kalbe Farma, Tbk.

The Best of Health Care Representative 2010, in PT. Pfizer Indonesia for Specialty Care and Oncology product